Session Chair: Sharon Tamir, United Neurosciences

The symposia will focus on advances in cognitive, visual and blood detected biochemical markers of the CNS

Session Faculty:
New Biomarkers and Therapeutic Strategies in Neurodevelopment Disorders.
Michela Fagiolini, PhD, Harvard Medical School

Cognitive Markers of Dementia in Primary Care.
Boaz Levy, PhD, University of Massachusetts

The Use of Biochemical and Imaging Biomarkers To Improve the Design of Clinical Trials of Acute CNS Injury Including Traumatic Brain Injury (TBI)
Ronald Hayes, PhD, Banyan Biomarkers

свернуть